193 related articles for article (PubMed ID: 34245315)
1. Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018.
Jensen MH; Hejlesen O; Vestergaard P
Diabetologia; 2021 Oct; 64(10):2193-2203. PubMed ID: 34245315
[TBL] [Abstract][Full Text] [Related]
2. Risk of major cardiovascular events, severe hypoglycaemia, and all-cause mortality for users of insulin degludec versus insulin glargine U100-A Danish cohort study.
Jensen MH; Hejlesen O; Vestergaard P
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3225. PubMed ID: 31647163
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures.
Jensen MH; Vestergaard P
Osteoporos Int; 2019 Aug; 30(8):1663-1670. PubMed ID: 31129687
[TBL] [Abstract][Full Text] [Related]
4. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
5. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
[TBL] [Abstract][Full Text] [Related]
6. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
[TBL] [Abstract][Full Text] [Related]
7. Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial.
Philis-Tsimikas A; Klonoff DC; Khunti K; Bajaj HS; Leiter LA; Hansen MV; Troelsen LN; Ladelund S; Heller S; Pieber TR;
Diabetologia; 2020 Apr; 63(4):698-710. PubMed ID: 31984443
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic hypoglycaemia in Type 1 diabetes: incidence and risk factors.
Henriksen MM; Andersen HU; Thorsteinsson B; Pedersen-Bjergaard U
Diabet Med; 2019 Jan; 36(1):62-69. PubMed ID: 30368899
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
Goldenberg RM; Aroda VR; Billings LK; Christiansen ASL; Meller Donatsky A; Parvaresh Rizi E; Podgorski G; Raslova K; Klonoff DC; Bergenstal RM
Diabetes Obes Metab; 2021 Nov; 23(11):2572-2581. PubMed ID: 34322967
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study.
Haukka J; Hoti F; Erästö P; Saukkonen T; Mäkimattila S; Korhonen P
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1326-35. PubMed ID: 24150837
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study.
Lin CH; Sheu WH
J Intern Med; 2013 Jan; 273(1):102-10. PubMed ID: 23003116
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized.
Nirantharakumar K; Marshall T; Kennedy A; Narendran P; Hemming K; Coleman JJ
Diabet Med; 2012 Dec; 29(12):e445-8. PubMed ID: 22937877
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
14. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.
Kulzer B; Seitz L; Kern W
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):167-72. PubMed ID: 24643694
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Waldenström A; Wedel H; Rydén L;
Heart; 2009 May; 95(9):721-7. PubMed ID: 19029171
[TBL] [Abstract][Full Text] [Related]
16. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
[TBL] [Abstract][Full Text] [Related]
17. Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes.
Fakhoury W; Lockhart I; Kotchie RW; Aagren M; LeReun C
Pharmacology; 2008; 82(2):156-63. PubMed ID: 18679040
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
Ratner RE; Gough SC; Mathieu C; Del Prato S; Bode B; Mersebach H; Endahl L; Zinman B
Diabetes Obes Metab; 2013 Feb; 15(2):175-84. PubMed ID: 23130654
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997-2017: Time trends in incidence and HbA
Bengtsen MB; Knudsen JS; Bengtsen MB; Møller N; Thomsen RW
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00227. PubMed ID: 34277957
[TBL] [Abstract][Full Text] [Related]
20. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
